A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Novo's blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

Two bereaved parents and 12 fellow members of an Australian religious congregation accused of killing an 8-year-old girl by ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...